The business model of ContextVision AB is focused on providing advanced medical imaging software solutions. The company develops and sells state-of-the-art image enhancement technologies for use in various medical imaging applications. ContextVision's software algorithms are designed to enhance image quality, optimize accuracy, and improve workflow efficiency. By partnering with leading original equipment manufacturers (OEMs) in the medical imaging industry, ContextVision aims to deliver innovative solutions that enable healthcare providers to obtain clearer and more accurate medical images. With a strong emphasis on research and development, ContextVision continuously strives to maintain its position as a trusted provider of advanced imaging solutions to improve patient care and diagnosis.

ContextVision AB is primarily active in the medical imaging industry.

The main competitors of ContextVision AB in the market include companies such as GE Healthcare, Siemens Healthineers, and Merge Healthcare. These companies also operate in the medical imaging and artificial intelligence software sectors, offering similar products and solutions. ContextVision AB strives to distinguish itself through its innovative technologies and advanced image enhancement solutions, ensuring enhanced image quality and accurate diagnoses for healthcare professionals. With a strong focus on research and development, ContextVision AB continuously aims to stay ahead of the competition and deliver cutting-edge software solutions to meet the evolving needs of the medical imaging industry.

ContextVision AB is a renowned company specializing in medical imaging software solutions. Established in 1983, the company has amassed a rich history and background in the medical technology domain. ContextVision AB focuses on developing innovative software, such as image enhancement, 3D visualization, and AI-based technologies, catering to healthcare providers and medical imaging equipment manufacturers globally. With its strong industry expertise and continuous research and development efforts, ContextVision AB has positioned itself as a leading provider of state-of-the-art imaging solutions. The company's dedication to quality and customer satisfaction has earned it a reputable name in the medical imaging industry.

ContextVision AB has successfully achieved several significant milestones over the years. Some noteworthy accomplishments include developing innovative software solutions for medical imaging, establishing strong partnerships with leading industry players, and receiving numerous prestigious awards for their cutting-edge technologies. Additionally, ContextVision AB has consistently demonstrated strong financial performance and growth, consolidating its position as a key player in the medical imaging market. These milestones highlight the company's commitment to innovation, excellence, and delivering value to its customers. ContextVision AB's achievements emphasize its reputation as a reliable and forward-thinking company in the field of medical imaging.

ContextVision AB is primarily present in several countries and regions. It has a strong presence in Europe, with a focus on Scandinavian countries such as Sweden, Norway, and Finland. The company also operates in other European regions including Germany and the United Kingdom. In addition to Europe, ContextVision AB has expanded its presence in the Asia-Pacific region, particularly in China and Japan. Furthermore, the company has a growing customer base in North America, particularly in the United States and Canada. ContextVision AB's global footprint allows it to cater to a wide range of customers and provide its innovative stock services worldwide.

ContextVision AB represents a strong set of values and corporate philosophy. The company is committed to delivering high-quality medical imaging software solutions to healthcare providers worldwide. ContextVision AB prioritizes innovation, collaboration, and customer satisfaction. With a strong focus on research and development, ContextVision AB continuously strives to enhance patient care and improve outcomes. By leveraging cutting-edge technology and expertise, the company aims to provide efficient and reliable solutions for medical image analysis and enhancement. ContextVision AB's commitment to excellence and customer-centric approach make it a trusted leader in the healthcare technology industry.

Analysts currently set an average price target of 4.04 SEK for the ContextVision stock (median: 4.04 SEK), implying +27.7 % versus the latest price. The consensus is based on 7 analyst ratings.

ContextVision Analyst Price Targets 2026

7 analysts currently rate the ContextVision stock: 0 recommend buying, 3 holding and 4 selling. For 2026, analysts expect ContextVision to generate revenue of 117.42 M SEK and earnings per share of 0.10 SEK.

ContextVision Analyst Price Targets 2026

Converted at the current exchange rate, the ContextVision share trades at 0.29 EUR (3.17 SEK).

The ContextVision share (CONTX.OL) is listed on 3 stock exchanges, including: London (0L8Z.L), London (0L8Z.L).

ContextVision AB is a leading provider of innovative solutions in the field of medical imaging. The company was founded in 1983 and currently employs over 100 employees. It has been listed on the Nasdaq Stockholm since 1999 and is headquartered in Stockholm, Sweden. ContextVision consists of four business areas that focus on specific segments of medical imaging: digital pathology, ultrasound, mammography, and radiography. Each business area offers a wide range of products and services aimed at improving precision, efficiency, and patient care. The product portfolio of ContextVision is tailored to the needs of medical professionals and clinicians who rely on accurate analysis and diagnosis of images. For example, the company offers a state-of-the-art software platform for digital pathology, allowing pathologists to digitally capture, store, and analyze histological images and data. This improves the accuracy of diagnosis and increases efficiency in pathology laboratories. Another example is the company's ultrasound division, which focuses on improving image quality and precision in ultrasound diagnostics. Through its image enhancement technology, ContextVision provides more productive diagnostic solutions that are faster and more accurate than conventional ultrasound systems. The company also offers solutions for mammography that target the detection of smaller tumors. Together, these offerings not only improve patient care but also contribute to reducing medical errors. ContextVision gains market share through partnerships with leading manufacturers of medical imaging devices. The company leverages its unique expertise in image analysis and enhancement to develop innovative solutions in collaboration with its partners. This collaboration has, for example, led to the development of the "GOPiCE" concept, which represents a benchmark in digital pathology. The range of solutions allows customers to create more efficient diagnoses while ensuring higher accuracy and reliability in patient care. Overall, ContextVision has secured its leading position in the field of medical imaging through the continuity of its performance and its willingness to adapt to the needs of its customers and partners. The company is committed to improving medical imaging and supporting its customers through innovative solutions. ContextVision is a pioneer in image analysis and an important component in the medical field.

The expected revenue of ContextVision is 117.42 M SEK. This figure is based on current financial data and reflects the company's business performance.

The expected profit of ContextVision is 7.83 M SEK. The net profit reflects the company's profitability after deducting all expenses.

The price-to-earnings ratio (P/E) of ContextVision is currently 30.74. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the ContextVision stock.

The price-to-sales ratio (P/S) of ContextVision is currently 2.05. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the ContextVision stock.

The Eulerpool Quality Score for ContextVision is 2/10.

The ISIN of ContextVision is SE0014731154. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The WKN of ContextVision is A2QA6S. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.

The ticker of ContextVision is CONTX.OL. The ticker symbol is used to trade ContextVision shares on the stock exchange.

Over the past 12 months, ContextVision paid a dividend of 0.45 SEK . This corresponds to a dividend yield of about 14.21 %. For the coming 12 months, ContextVision is expected to pay a dividend of 0.45 SEK.

The current dividend yield of ContextVision is 14.21 %.

ContextVision pays a dividend, distributed in the months of , , , .

ContextVision paid dividends every year for the past 0 years.

For the upcoming 12 months, dividends amounting to 0.45 SEK are expected. This corresponds to a dividend yield of 14.21 %.

ContextVision is assigned to the 'Health' sector.

To receive the latest dividend of ContextVision from amounting to 0.15 SEK, you needed to have the stock in your portfolio before the ex-date on .

The last dividend was paid out on .

The dividends of ContextVision are distributed in SEK.